Anti-TNFRSF9 (ECD domain) Neutralizing Antibody (V3S-0622-YC5675) (CAT#: V3S-0622-YC5675)

Send Inquiry
  • fig1
    Figure 1 Anti-TNFRSF9 Monoclonal Antibody (V3S-0622-YC5675) in SDS-PAGE
  • fig1
    Figure 2 Anti-TNFRSF9 Monoclonal Antibody (V3S-0622-YC5675) in SEC-HPLC
  • fig1
    Figure 3 Anti-TNFRSF9 Monoclonal Antibody (V3S-0622-YC5675) in WB
  • fig1
    Figure 4 Anti-TNFRSF9 Monoclonal Antibody (V3S-0622-YC5675) in ELISA

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with TNFRSF9. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Immunogen Ectodomain of human 4-1BB recombinant protein.
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application WB; ELISA; FC; IP; FuncS; IF; Neut; ICC
Application Notes The antibody is recommended for detection of TNFRSF9 by ELISA, FC, IP, FuncS, IF, Neut, ICC assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target TNFRSF9
Alternative Name TNFRSF9; tumor necrosis factor receptor superfamily, member 9; ILA; tumor necrosis factor receptor superfamily member 9; 4 1BB; CD137; CD137 antigen; T cell antigen ILA; T-cell antigen ILA; 4-1BB ligand receptor; homolog o
Gene ID 3604
UniProt Q07011
Research Area Cell Biology; Immunology

Tested Data

SDS-PAGE

Figure 1 Anti-TNFRSF9 Monoclonal Antibody (V3S-0622-YC5675) in SDS-PAGE

SDS-PAGE analysis of V3S-0622-YC5675 in non-reduced and β-mercaptoethanol-reduced conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively. And non-reduced protein migrates as 180 kDa.

Figure 1 Anti-TNFRSF9 Monoclonal Antibody (V3S-0622-YC5675) in SDS-PAGE

SEC-HPLC

Figure 2 Anti-TNFRSF9 Monoclonal Antibody (V3S-0622-YC5675) in SEC-HPLC

The purity of V3S-0622-YC5675 was greater than 94% as determined by SEC-HPLC.

Figure 2 Anti-TNFRSF9 Monoclonal Antibody (V3S-0622-YC5675) in SEC-HPLC

WB

Figure 3 Anti-TNFRSF9 Monoclonal Antibody (V3S-0622-YC5675) in WB

Western blot analysis of V3S-0622-YC5675 was performed by loading Recombinant Human CD137 Protein (His Tag) (1 μg) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk.
Lane 1: Non-Reducing Antigen (1 μg)
Lane 2: Reducing Antigen (1 μg)

Figure 3 Anti-TNFRSF9 Monoclonal Antibody (V3S-0622-YC5675) in WB

ELISA

Figure 4 Anti-TNFRSF9 Monoclonal Antibody (V3S-0622-YC5675) in ELISA

ELISA analysis of V3S-0622-YC5675 was performed by coating with Recombinant Human CD137 Protein (His Tag).

Figure 4 Anti-TNFRSF9 Monoclonal Antibody (V3S-0622-YC5675) in ELISA

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry